CAPR icon

Capricor Therapeutics

32 hedge funds and large institutions have $12.5M invested in Capricor Therapeutics in 2023 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$528K
Puts
$166K
Net Calls
Net Calls Change

Top Buyers

1 +$375K
2 +$319K
3 +$147K
4
GCP
GSA Capital Partners
United Kingdom
+$86K
5
BlackRock
BlackRock
New York
+$81K

Top Sellers

1 -$354K
2 -$71K
3 -$22.1K
4
UBS Group
UBS Group
Switzerland
-$18.7K
5
BAM
Belpointe Asset Management
Nevada
-$8.73K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$5.48M
2
$1.96M
3
$1.43M
4
$504K
5
$406K
6
$404K
7
$375K
8
$254K
9
$232K
10
$222K
11
$218K
12
$143K
13
$127K
14
$117K
15
$115K
16
$86K
17
$64.4K
18
$63.4K
19
$58.5K
20
$52.1K
21
$48K
22
$41.8K
23
$38.5K
24
$35.7K
25
$28.7K